Rhythm notes · ECG Simulator
Torsades de pointes
Clinical review pending: written from the sources below, not yet checked by a clinician. Updated 2026-11-22.
In one line
A fast, polymorphic ventricular tachycardia whose QRS complexes seem to twist around the baseline, growing and shrinking, in a heart whose repolarization is delayed (a long QT).1,2
Mechanism
- The QT interval spans ventricular depolarization and repolarization. Anything that delays repolarization lengthens the action potential and the QT: long QT syndrome.1
- A long action potential lets early afterdepolarizations appear: small extra upswings before the cell has fully recovered. Repeated, they can trigger extra beats.1,3
- The classic onset is short–long–short: a premature beat, a pause, then a beat with an even longer QT, which sets off the arrhythmia.1,2
- The name means "twisting of the points": the QRS axis rotates, so the peaks seem to wind around the baseline.1
- Most drugs that cause it block the potassium current (IKr, carried by the hERG channel) that ends the action potential.3
- Episodes often stop on their own but can recur, and can degenerate into ventricular fibrillation.1,2
Epidemiology
- Torsades is uncommon, but drug-induced QT prolongation and torsades have been a leading reason for drugs being restricted or withdrawn.3
- In hospitals, the risk is highest in people with several risk factors at once, such as older women on QT-prolonging drugs with low potassium.2
- Congenital long QT syndromes are rare, caused by mutations in potassium or sodium channel genes. Acquired forms are much more common.1
Causes and risk factors
- QT-prolonging drugs: some antiarrhythmics (such as quinidine and sotalol), antibiotics such as fluoroquinolones and erythromycin, some antipsychotics and antiemetics, methadone and others.1,2,3
- Electrolytes: low potassium, low magnesium, low calcium.1,2
- Female sex, older age, slow heart rates, heart failure and recent conversion from AF.2,3
- Congenital long QT syndrome.1,2
- Combinations of the above, which add up.2,3
How to spot it
- Rate: fast, often 150–250 a minute.2
- QRS: wide and polymorphic, with amplitude waxing and waning in a spindle pattern.1,2
- Baseline QT: the beats before the run show a long QT (or QTc). A QTc over 500 ms marks high risk.2
- Onset: often a short–long–short sequence: PVC, pause, long-QT beat, then torsades.1,2
- Course: short self-ending bursts that recur, or a run that degenerates into VF.1,2
Differential diagnosis
- Polymorphic VT with a normal QT: looks similar, but the baseline QT is normal; it is usually caused by acute ischemia, and treated differently.2,4
- Monomorphic VT: wide, but every QRS looks the same.4
- Ventricular fibrillation: no recognizable QRS complexes at all.1
- Artifact: movement or loose leads can mimic it; check the patient and other leads.2
Clinical picture
Why it matters
Management overview
For learning only. This is the shape of care, not a treatment plan; real decisions depend on the patient and the current guideline.
- Pulseless or degenerating into VF: CPR and defibrillation.5
- Intravenous magnesium is the classic acute treatment, even when the magnesium level is normal.1,2
- Stop every QT-prolonging drug and correct potassium and magnesium.2,3
- Speed the heart up in pause-dependent torsades (for example temporary pacing), because slow rates lengthen the QT.2,4
- Congenital long QT: beta-blockers long term, and an implantable defibrillator for some.1,4
Exam pearls
Try it
See it move.
Compare with its lookalikes:
Sources
Where this comes from.
- Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology, 14th ed. Elsevier; 2021. Ch. 13 (pp. 161–162).
- Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121(8):1047–60. doi.org/10.1161/CIRCULATIONAHA.109.192704
- Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013–22. doi.org/10.1056/NEJMra032426
- Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 2018;138(13):e272–e391. doi.org/10.1161/CIR.0000000000000549
- Panchal AR, Bartos JA, Cabañas JG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16 suppl 2):S366–S468. doi.org/10.1161/CIR.0000000000000916